The fast pace of AI development in healthcare is raising questions about who will lead the regulatory charge: industry or the government. FDA Commissioner Robert Califf acknowledges the risk of AI outpacing regulation but believes the system will eventually self-correct. He emphasizes the need for shared accountability, particularly urging health systems to take responsibility for potential liabilities associated with AI algorithms.
Meanwhile, pharmaceutical companies like Novo Nordisk are preparing for price negotiations under the Inflation Reduction Act, while innovative startups are pushing the boundaries of AI in healthcare. From Apple Watch's sleep apnea detection to brain-computer interfaces and personalized medicine through RNA editing, AI is transforming the landscape of healthcare
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Societal factors can shape how companies best respond after customers misbehaveFrom rule breaking and theft to verbal abuse and foul language, one customer's behavior can negatively affect another customer's experience.
더 많은 것을 읽으십시오 »
Billionaires Shape Global Finance Through Strategic Investments And Bold TradesLearn how billionaires like Elon Musk, Jeff Bezos, and Bernard Arnault are shaping global finance with their strategic investments and bold trades. Discover the trends and strategies that drive their success.
더 많은 것을 읽으십시오 »